Answers are grounded in this paper and cite their sources.
Purpose It is unclear whether the use of contrast enhanced (CE) CT for attenuation correction (AC) of [18F]FDG PET leads to higher quantification inaccuracies when used in high-sensitivity LAFOV systems. This project aimed to assess the clinical feasibility of CE-CT for AC in LAFOV-PET for lymphoma patients. Methods Lymphoma patients who underwent LAFOV-[18F]FDG-PET for restaging with low dose AC-CT and diagnostic CE-CT were included in this retrospective analysis. PET images were reconstructed using ultra-high sensitivity (UHS) mode with CE-CT and AC-CT. Lesions and reference regions (liver and mediastinal blood pool (BP)) were evaluated. Results SUVmax of BP and the liver increased when CE-CT was used instead of AC-CT for AC (BP: median 2.41vs.2.21, p < 0.01, 8.78% intra-patient increase; liver: 3.07vs.2.87, p < 0.01, 7.86% medina intra-patient increase). Similarly, SUVmean was higher in CE-CT reconstructions (BP: 1.96vs.1.77, p < 0.01, 10.14% median intra-patient increase; liver: 2.50vs.2.32, p < 0.01, 7.54% median intra-patient increase). SUVmax of lesions showed a similar magnitude of increase (5.97vs.5.68, p < 0.01, 5.80% median intra-lesion increase). The SUV-ratio of the lesions to reference organs decreased when CE-CT instead of AC-CT was used for AC (BP: 2.79vs.2.99, p < 0.01, median per-lesion decrease - 4.90%; liver: 1.85vs.1.97, p < 0.01, median per-lesion decrease - 2.64%). Conclusion The use of CE-CT for AC of LAFOV-PET in UHS mode leads to higher SUV measurements. Also, lymphoma lesions show a consistent increase in uptake. The errors in the lesions seem higher than in conventional standard axial field-of-view PETs that use CE-CT for AC. Therefore, interpretation of borderline cases warrants attention to potential errors.
No takes yet. Share an insight, caveat, or question.
Penner et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: